Hospital
Palo Verde Health Care District
Palo Verde Health Care District was paid $2.67M by Medicaid between Jan 2018 and Nov 2024, across 123 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoPALO VERDE HEALTH CARE DISTRICT
BLYTHE, CA 92225
BLYTHE, CA 92225
33aNPI1194705202assigned 01/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.67M
24GClaims129,891
24DCodes billed123
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#250 of 410
Median peer was paid$6.90M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,368 | $302K | |
| 2019 | 14,411 | $247K | |
| 2020 | 11,076 | $164K | |
| 2021 | 13,396 | $248K | |
| 2022 | 25,783 | $588K | |
| 2023 | 31,286 | $686K | |
| 2024incomplete | 18,571 | $436K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 9,373 | 8,240 | $475K |
| Z7502 | 9.6% | 6,789 | 6,499 | $257K | |
| 80053 | Comprehensive metabolic panel | 5.9% | 12,388 | 11,210 | $157K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.5% | 1,040 | 988 | $146K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.1% | 14,887 | 13,516 | $136K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.6% | 2,143 | 1,990 | $123K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.7% | 2,094 | 1,962 | $99K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.7% | 981 | 941 | $98K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 2,014 | 1,942 | $84K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 1,821 | 1,694 | $79K |
| Z7610 | 2.8% | 5,830 | 3,810 | $74K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.7% | 3,258 | 2,971 | $73K |
111 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 2.5% | 1,641 | $67K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 1,610 | $67K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.2% | 964 | $59K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 2,838 | $55K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.8% | 1,839 | $47K |
| 81000 | 1.3% | 8,363 | $35K | |
| 0450 | Emergency room services | 1.3% | 762 | $35K |
| 87428 | 1.1% | 534 | $29K | |
| 99499 | 1.1% | 520 | $29K | |
| 84484 | <1% | 2,067 | $26K | |
| 99284 | Emergency room visit (serious) | <1% | 361 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,232 | $25K |
| 80061 | Lipid panel | <1% | 1,207 | $21K |
| 99070 | <1% | 7,058 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,427 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,351 | $18K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 886 | $18K |
| 83880 | <1% | 768 | $17K | |
| 84703 | <1% | 1,317 | $16K | |
| 83735 | <1% | 1,960 | $16K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 67 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 73 | $12K |
| 83690 | <1% | 1,261 | $12K | |
| 85730 | <1% | 1,485 | $11K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 194 | $10K |
| 87400 | <1% | 2,007 | $10K | |
| 82553 | <1% | 688 | $10K | |
| 82150 | <1% | 1,082 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,021 | $9K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 181 | $8K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 150 | $8K |
| 86756 | <1% | 315 | $7K | |
| 85610 | <1% | 1,501 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,462 | $6K |
| 85379 | <1% | 376 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 531 | $5K |
| 72131 | <1% | 29 | $5K | |
| 84702 | <1% | 258 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 353 | $5K |
| 94664 | <1% | 325 | $4K | |
| 83874 | <1% | 258 | $4K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 252 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,519 | $4K |
| 83605 | <1% | 214 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 38 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 328 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,277 | $3K |
| 82550 | <1% | 375 | $3K | |
| 71250 | <1% | 25 | $3K | |
| Z7506 | <1% | 18 | $3K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 993 | $3K |
| 86141 | <1% | 234 | $2K | |
| 93226 | <1% | 40 | $2K | |
| 85651 | <1% | 394 | $2K | |
| 90715 | <1% | 57 | $2K | |
| 99218 | <1% | 12 | $2K | |
| 71020 | <1% | 55 | $1K | |
| 86901 | <1% | 179 | $1K | |
| 87210 | <1% | 176 | $1K | |
| 86850 | <1% | 103 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 269 | $1K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 17 | $777.58 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 534 | $723.84 |
| 80202 | <1% | 30 | $653.92 | |
| 82043 | <1% | 116 | $606.22 | |
| 73630 | <1% | 13 | $549.69 | |
| 73562 | <1% | 26 | $544.40 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $535.80 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 35 | $528.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 133 | $517.94 |
| Z7512 | <1% | 18 | $470.34 | |
| 82270 | <1% | 109 | $458.13 | |
| 84436 | <1% | 57 | $445.20 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 103 | $410.29 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 432 | $409.20 |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 12 | $401.64 |
| 72100 | <1% | 13 | $361.40 | |
| 99406 | <1% | 35 | $333.12 | |
| 99217 | <1% | 12 | $313.56 | |
| 83615 | <1% | 59 | $290.44 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 29 | $285.66 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 725 | $273.08 |
| 96368 | <1% | 13 | $268.54 | |
| 73130 | <1% | 12 | $261.80 | |
| 81025 | <1% | 40 | $250.58 | |
| 73030 | <1% | 12 | $249.61 | |
| 86900 | <1% | 55 | $247.69 | |
| 80185 | <1% | 14 | $240.11 | |
| 97802 | <1% | 17 | $236.73 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 57 | $229.06 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 39 | $219.29 |
| 84439 | <1% | 13 | $203.64 | |
| J3490 | Unclassified drugs | <1% | 548 | $197.41 |
| 82077 | <1% | 14 | $193.48 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,930 | $189.83 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 34 | $187.11 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 48 | $166.23 |
| J2704 | Injection, propofol, 10 mg | <1% | 28 | $153.66 |
| 73100 | <1% | 12 | $147.35 | |
| 83540 | <1% | 13 | $139.49 | |
| 0250 | <1% | 29 | $108.33 | |
| 85044 | <1% | 16 | $91.44 | |
| 85027 | <1% | 13 | $82.52 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 49 | $74.69 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 16 | $56.06 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 16 | $35.67 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 16 | $33.77 |
| 80076 | <1% | 15 | $32.61 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $7.71 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $3.95 |
| 0250R | 0% | 778 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANAYA, SANDRA (CEO)